Clin2
NCT07792915Possibly a fitNot yet recruiting

Potato starch to clear resistant gut bacteria

Clostridium InfectionsMethicillin-resistant Staphylococcus Aureus (MRSA)Vancomycin-Resistant EnterococciCarbapenem-Resistant EnterobacteriaceaeAsymptomatic Infections

Part of Infections clinical trials.

This trial tests whether taking a special potato starch daily can help remove resistant bacteria from your gut. It may lower the chance of future infections.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
120 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have resistant bacteria in your gut, like C. difficile, MRSA, VRE, or certain types of E. coli.
  • You are not in the hospital and can move around normally.
  • You do not have a history of bowel blockages, severe gut disease, or trouble swallowing.
  • Your diabetes is well-controlled and you haven't been hospitalized for it in the past 5 years.
  • You haven't had a fecal transplant, gut surgery, or taken probiotics/fiber supplements in the last month.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06001333Recruiting
Fecal transplant to clear superbugs from the gut

This study tests whether a fecal transplant (FMT) can remove certain antibiotic-resistant bacteria from your gut. It might help people who carry superbugs like CPE or VRE but aren't currently on antibiotics.

Chuncheon, Gangwon-do
NCT06425380Recruiting
Resistant potato starch for liver cirrhosis and confusion

This study is testing whether a special type of starch (resistant potato starch) can help people with cirrhosis who have had episodes of confusion from liver problems. It may help by changing the bacteria in your gut, which could reduce the risk of future confusion episodes.

Rochester, Minnesota
NCT04188743Recruiting· Phase 2/Phase 3
Stool transplant to clear antibiotic-resistant gut germs

This trial tests whether a stool (fecal) transplant from a screened donor can help remove antibiotic-resistant gut bacteria (MDRO) that keep coming back in your stool tests. It aims to reduce colonization that makes follow-up and treatment harder.

Ghent, Oost-Vlaanderen
NCT04759001Recruiting· Phase 1/Phase 2
Fecal treatment to clear gut bacteria resistant to antibiotics

This study tests a stool-based treatment (fecal microbiota treatment) to help remove “carbapenem-resistant” bacteria living in the gut. If you carry these bacteria without being sick, the goal is to reduce or stop that colonization.

Rome
NCT06337812Recruiting
Fiber supplement study for heart failure and diabetes

This study tests whether adding a daily fiber supplement can improve health in people with heart failure and type 2 diabetes. Participants take the supplement for several weeks to see if it helps manage symptoms and blood sugar.

Ann Arbor, Michigan
NCT07106580Recruiting· Phase 1/Phase 2
Fecal transplant capsules for clearing drug-resistant bacteria from the gut

This trial tests whether taking capsules containing processed healthy donor stool (fecal microbiota transplant) can safely remove certain drug-resistant bacteria (like CRE, ESBL-E, and VRE) from your intestines. It may be an option for people who have these bacteria in their stool but are not currently being treated with antibiotics.

Rijeka

Hear when a new Carbapenem-Resistant Enterobacteriaceae trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.